Literature DB >> 15642860

Familial periodic paralysis and Charcot-Marie-Tooth disease in a 7-generation family.

Fuki M Hisama1.   

Abstract

BACKGROUND: A family with a complicated constellation of neurologic findings, including neuropathy, myotonia, and periodic paralysis, has been described in 4 studies in the medical literature since 1934. The underlying cause of their disease has been the subject of considerable speculation and has never been identified until now.
OBJECTIVE: To identify the molecular basis of this family's neurologic disease.
DESIGN: The coding regions of 6 genes that cause peripheral neuropathy and regions of the muscle sodium channel gene (SCN4A) were sequenced.
RESULTS: A novel missense mutation (Arg67Pro) in the myelin protein zero gene was identified in 2 patients with Charcot-Marie-Tooth disease, and a common missense mutation (Thr704Met) was identified in the SCN4A gene in 4 family members. We discuss the difficulties of genotype-phenotype correlation in this family.
CONCLUSIONS: These findings indicate that 2 independent mutations segregating in this family are responsible for the puzzling clinical picture.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642860     DOI: 10.1001/archneur.62.1.135

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  2 in total

1.  Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype.

Authors:  Ilaria Callegari; C Gemelli; A Geroldi; F Veneri; P Mandich; M D'Antonio; D Pareyson; M E Shy; A Schenone; V Prada; M Grandis
Journal:  J Neurol       Date:  2019-07-05       Impact factor: 4.849

2.  Coexistence of Charcot-Marie-Tooth 1A and nondystrophic myotonia due to PMP22 duplication and SCN4A pathogenic variants: a case report.

Authors:  Haitian Nan; Yunqing Wu; Shilei Cui; Houliang Sun; Jiawei Wang; Ying Li; Lingchao Meng; Takamura Nagasaka; Liyong Wu
Journal:  BMC Neurol       Date:  2022-01-07       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.